Skip to content

Study · Not a test of the peptide alone · 2015

3 results

Evaluation of dermal extracellular matrix and epidermal-dermal junction modifications using matrix-assisted laser desorption/ionization mass spectrometric imaging, in vivo reflectance confocal microscopy, echography, and histology: effect of age and peptide applications.

Mondon P, Hillion M, Peschard O, Andre N, Marchand T, Doridot E, Feuilloley MG, Pionneau C, Chardonnet S

Journal of cosmetic dermatology27 Mar 2015Cited by 17 (Europe PMC)

PMID25817264 (opens in a new tab)DOI10.1111/jocd.12135 (opens in a new tab)PepBankPUB-25817264
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Palmitoyl tetrapeptide-7 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Palmitoyl tetrapeptide-7.

  1. 01HumanNot a test of Palmitoyl tetrapeptide-7 aloneNon-randomized trialEfficacy outcome

    In skin evaluations, the peptide blend reduced subepidermal low-echogenic band thickness.

    In plain wordsThe peptide blend reduced the thickness of a skin band measured by ultrasound.

    Peptide
    Palmitoyl tetrapeptide-7
    Outcome
    DecreaseSubepidermal low-echogenic band thickness
    Study

    n: not reported in source

    Outcome group
    Skin and hair · Skin and wound

    Source sentences

    Summary
    Echography demonstrated that the peptide blend reduced subepidermal low-echogenic band thickness and improved its density.
    1 context sentence
    Summary · context
    Anti-aging molecule evaluations were performed with a blend of palmitoyl oligopeptide and palmitoyl tetrapeptide-7.

    In this study, Palmitoyl tetrapeptide-7 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Palmitoyl tetrapeptide-7.

  2. 02HumanNot a test of Palmitoyl tetrapeptide-7 aloneNon-randomized trialEfficacy outcome

    In skin evaluations, the peptide blend improved subepidermal low-echogenic band density.

    In plain wordsThe peptide blend improved the density of a skin band measured by ultrasound.

    Peptide
    Palmitoyl tetrapeptide-7
    Outcome
    IncreaseSubepidermal low-echogenic band density
    Study

    n: not reported in source

    Outcome group
    Skin and hair · Skin and wound

    Source sentences

    Summary
    Echography demonstrated that the peptide blend reduced subepidermal low-echogenic band thickness and improved its density.
    1 context sentence
    Summary · context
    Anti-aging molecule evaluations were performed with a blend of palmitoyl oligopeptide and palmitoyl tetrapeptide-7.

    In this study, Palmitoyl tetrapeptide-7 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Palmitoyl tetrapeptide-7.

  3. 03HumanNot a test of Palmitoyl tetrapeptide-7 aloneNon-randomized trialEfficacy outcome

    In skin evaluations, the peptide blend improved ECM structure versus placebo.

    In plain wordsThe peptide blend improved skin support structure compared with placebo.

    Peptide
    Palmitoyl tetrapeptide-7
    Outcome
    IncreaseECM structure
    Study

    n: not reported in source

    Comparator
    placebo
    Outcome group
    Skin and hair · Skin and wound

    Source sentences

    Summary
    In vivo RCM studies indicated that the peptides improved the ECM structure vs. placebo.
    1 context sentence
    Summary · context
    Anti-aging molecule evaluations were performed with a blend of palmitoyl oligopeptide and palmitoyl tetrapeptide-7.

    In this study, Palmitoyl tetrapeptide-7 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Palmitoyl tetrapeptide-7.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    27 Oct 2026, 18:20 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:32 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.